![]() |
Leo Borchardt
Mr. Borchardt is a partner in Davis Polk’s Corporate Department, practicing in the London office. He has advised large corporations, boards of directors, special committees and investment banks on a variety of significant capital markets, cross-border M&A and other strategic corporate transactions. He also regularly advises clients on corporate governance, reporting and compliance and general corporate matters. Mr. Borchardt is bilingual in German and English. |
Work Highlights
Mergers and Acquisitions
- Reliance Industries Limited in connection with:
- The establishment of its 51%/49% joint venture with BP relating to their petroleum retail business in India
- An unprecedented series of capital raisings for Jio Platforms Limited totaling over $10 billion from world leading strategic and financial investors including Google, PIF, Mubadala, ADIA, TPG, Intel and Qualcomm
- Its agreement to acquire wireless infrastructure assets from Reliance Communications
- Celonis on its acquisition of Integromat
- Mereo BioPharma on its combination with OncoMed Pharmaceuticals
- Telia Company on the:
- $1.03 billion sale of its holding in Nepalese telecom operator Ncell to Axiata
- Sale of its interest in Tajik telecom operator Tcell to AKFED
- Sale of its interest in Afghan telecom operator Roshan to AKFED
- Technip on its $17 billion business combination with FMC Technologies
- Bertelsmann in connection with its Penguin Random House venture with Pearson
- XL Group on the establishment of a joint venture with Stone Point Capital
- Pattern Energy’s committee of independent directors on the acquisitions of six wind power projects
- A major European telecom operator on its anchor investment in a VC fund
- Affiliates of Morgan Stanley in connection with the bankruptcy of Anthracite Capital
- Sterling Financial on its $2 billion merger with Umpqua and related divestitures
- MSCI in its acquisition of IPD Group
- ThyssenKrupp on U.S. aspects of the sale of its stainless steel business
Capital Markets
Equity
- Centogene on its IPO and U.S. listing and its primary and secondary follow-on transaction
- Mereo BioPharma on its U.S. listing
- The underwriters on Handicare’s SEK 1 billion IPO
- The underwriters on CEVA Logistics’ CHF 1.1 billion IPO
- Boozt on its SEK 1.85 billion IPO
- The underwriters on Deutsche Bank’s €8.0 billion (2017), €6.7 billion (2014) and €10.2 billion (2010) SEC-registered rights offerings
- Scout24 on its €1.2 billion IPO
- The underwriters on Schaeffler’s €938 million IPO
- Tele Columbus on its €367 million IPO and €383 million follow-on offering
- The underwriters on NXP’s $476 million SEC-registered IPO and a $1 billion SEC-registered secondary follow-on offering
- The underwriters on Erste Group's €1.7 billion rights offering
- Julius Baer on the spin off of its asset management business
- HeidelbergCement on its €4.4 billion primary and secondary re-IPO
Debt
- The underwriters on SEC-registered offerings of regulatory capital by Deutsche Bank:
- $1.25 (2020) and $1.5 billion (2014) additional Tier 1 (AT1) notes
- $500 million (2020) and $1.0 billion (2017) subordinated Tier 2 notes
- SEC-registered notes offerings for AstraZeneca and BBVA (issuer side) and Diageo, Equinor, Linde, OeKB and Rio Tinto (underwriters side), totaling more than $49 billion
- Rule 144A notes offerings of Roche and a leading German automobile manufacturer (issuer side) and Crédit Agricole, Fresenius Medical Care, NXP and Yara International (underwriters side), totaling more than $25 billion
Of Note
- Fellow, Royal Society of Arts
- Member, Royal Institute of International Affairs, Chatham House
- Erasmus Scholar, Institut d’Etudes Politiques de Paris, 2002-2003
- Visiting Scholar, Max Planck Institute for International Law, Heidelberg, 2006-2007
Professional History
- Partner, 2016-present
- Associate, 2008-2016
- London office, 2009-2012 and 2014-present
- New York office, 2012-2014
- Frankfurt office, 2008-2009
- Judicial Clerk, Court of Appeals of Graz, 2008